Square Pharma directors give a hand to the market
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
January 27, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, JANUARY 27, 2023
Square Pharma directors give a hand to the market

Corporates

TBS Report
17 January, 2020, 03:55 pm
Last modified: 18 January, 2020, 10:38 am

Related News

  • New drugs, strong marketing help Square Pharma maintain growth trend
  • Square Pharma projects lower revenue and profit due to a fire incident
  • Square Pharma’s quarterly profit rise by 18%
  • Four directors to buy 9 lakh Square Pharma shares
  • Square Pharma continues business growth in pandemic

Square Pharma directors give a hand to the market

Chairman Samuel S Chowdhury and Managing Director Tapan Chowdhury will buy 6 lakh shares from public market and the declaration helped boost market confidence on blue chip stocks

TBS Report
17 January, 2020, 03:55 pm
Last modified: 18 January, 2020, 10:38 am
Square Pharma maintained an average of 18.4 percent annual profit growth over the last seven years/Photo: Courtesy
Square Pharma maintained an average of 18.4 percent annual profit growth over the last seven years/Photo: Courtesy

Market adversity has been pushing Square Pharmaceuticals Ltd shares, like all other blue-chip shares listed in the Dhaka Stock Exchange (DSE), at a devastating low despite the company fundamentals were in positive direction.

Amid continuous fall, mainly because of an adamant sell off from foreign-owned portfolios, the darling of the market did not even take two months to lose more than one-fourth of its price at the Dhaka Stock Exchange until middle of the last week. 

On November 21, 2019 Square Pharma shares were traded at Tk 220 each at the DSE, which touched Tk 161 on last Tuesday.  

At such a bad time, on Thursday morning, the company announced that both their board Chairman Samuel S Chowdhury and Managing Director Tapan Chowdhury will buy 3 lakh shares each from the public market. The shares will be bought from the bourses of Dhaka and Chattogram within 30 working days. 

Investors shocked by the recent price fall were assured that the key people of the company are optimistic about the business and thus increasing their stake in the company, according to analysts. 

Square Pharma also helped increase investors' focus to blue-chip shares, which had a good day at the bourse on Thursday.  

The company came up at the top of the turnover list at the DSE, with a 7.5 percent price hike, which supported the market indices to recover as well. 

The largest pharmaceutical company of the country is in the third spot at the DSE in terms of market capitalisation. With a market capitalisation of over TK15,000 crore the company is contributing 5.71 percent to the DSE's total. 

Equity research note from BRAC EPL Stock Brokerage reveals, Square Pharma has maintained an average of 18.4 percent annual profit growth over last seven years, while annual average return from its shares was 12.2 percent. 

The analysts at the investment research team had prescribed its clients in private to start buying Square Pharma shares at a rate over Tk 200 few months earlier. They still hold the recommendation with an increased weight as the stock is much cheaper now, according to a latest note the team sent to some selective clients.  

Square Pharma posted Tk16.03 earnings per share for the fiscal year of 2018-19. Its shareholders got 42 percent cash and 7 percent stock dividend for the year. 

Over the July-September quarter of 2019 the company posted an EPS of Tk 4.25, which was 4.02 for the same period of the previous year. On September 30, 2019 its net asset value per share was Tk 90. 

The company closed at Tk178.40 per share on Thursday. 

Sponsors and directors collectively hold 34.43 percent of Square Pharma shares, while institutional investors possess 10.28 percent, foreign portfolio investors 19.83 percent and general public owns remaining 35.46 percent.

Square Pharmaceuticals Ltd
Launched in 1958, Square Pharmaceuticals emerged as the industry leader in the mid-1980s, and got listed in the local stock exchange in the mid-1990s.

Company annual report reveals that the company, with around 17 percent market share, is selling a wide range of pharmaceutical products worth over Tk4,500 crore per year.

Moreover, it currently exports its products to over 40 countries, and that is expected to increase further in coming days.

It is a cash-rich company with no debt for the last few years.

Top News / Pharma

Square Pharma

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Manufacturers feel the pinch as consumers tighten belt
    Manufacturers feel the pinch as consumers tighten belt
  • Sugar turning bitter!
    Sugar turning bitter!
  • Island hopping in Bangladesh?
    Island hopping in Bangladesh?

MOST VIEWED

  • High paid-up capital for OPCs hampering SME growth: BUILD
    High paid-up capital for OPCs hampering SME growth: BUILD
  • BGMEA calls on PVH to buy more high-end apparels from Bangladesh
    BGMEA calls on PVH to buy more high-end apparels from Bangladesh
  • Passage of revised tobacco control act needed to protect public health: State minister
    Passage of revised tobacco control act needed to protect public health: State minister
  • Photo: PR
    AIBL opens 209th branch at Courtbazar, Cox's Bazar
  • DPS STS School Dhaka organises 'Amar Desh, Amar Garbo' to honor freedom fighters
    DPS STS School Dhaka organises 'Amar Desh, Amar Garbo' to honor freedom fighters
  • Photo: Courtesy
    BAT Bangladesh recognised as top employer in 2023

Related News

  • New drugs, strong marketing help Square Pharma maintain growth trend
  • Square Pharma projects lower revenue and profit due to a fire incident
  • Square Pharma’s quarterly profit rise by 18%
  • Four directors to buy 9 lakh Square Pharma shares
  • Square Pharma continues business growth in pandemic

Features

Island hopping in Bangladesh?

Island hopping in Bangladesh?

1h | Panorama
According to the CAB president Ghulam Rahman, one of the most common complaints of consumers is being deceived by sellers when it comes to the weight of goods. Photo: TBS

Has the Directorate improved consumer rights in Bangladesh?

2d | Panorama
A 2022 survey of 1,000 companies by professional services consultancy PwC found that between a sixth and a quarter had used AI in recruitment or employee retention in the past 12 months. Illustration: Bloomberg

AI is coming to your workplace. Is the world ready?

2d | Panorama
Edison Desdemona, the newly launched stellar project of Edison Real Estate, located at Bashundhara Residential Area. Photo: Courtesy

EDISON DESDEMONA: A creation like no other

2d | Habitat

More Videos from TBS

Kajol’s road paintings bring change in Gafargaon

Kajol’s road paintings bring change in Gafargaon

13h | TBS Stories
Carew & Company witnessed a remarkable growth

Carew & Company witnessed a remarkable growth

14h | TBS Stories
PCB recalls cricketers from BPL ahead of PSL

PCB recalls cricketers from BPL ahead of PSL

16h | TBS SPORTS
Why Misha Sawdagar became villain instead of a Hero?

Why Misha Sawdagar became villain instead of a Hero?

15h | TBS Entertainment

Most Read

1
Picture: Collected
Bangladesh

US Embassy condemns recent incidents of visa fraud

2
Four top bankers arrested in DSA case filed by S Alam group 
Bangladesh

Four top bankers arrested in DSA case filed by S Alam group 

3
Illustration: TBS
Banking

16 banks at risk of capital shortfall if top 3 borrowers default

4
Photo: Collected
Splash

Hansal Mehta responds as Twitter user calls him 'shameless' for making Faraaz

5
A frozen Beyond Burger plant-based patty. Photographer: AKIRA for Bloomberg Businessweek
Bloomberg Special

Fake meat was supposed to save the world. It became just another fad

6
Representational Image
Banking

Cash-strapped Islami, Al-Arafah and National turn to Sonali Bank for costly fund

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]